Citations (4)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Matthew Driban, Nikita Kedia, Supriya Arora & Jay Chhablani. (2023) Novel pharmaceuticals for the management of retinal vein occlusion and linked disorders. Expert Review of Clinical Pharmacology 16:11, pages 1125-1139.
Read now
Read now
Alessandro Arrigo & Francesco Bandello. (2021) Retinal vein occlusion: drug targets and therapeutic implications. Expert Opinion on Therapeutic Targets 25:10, pages 847-864.
Read now
Read now
Articles from other publishers (2)
S. Karimi, H. Nikkhah, H. Nafisi, H. Nouri, I. Ansari, S. Barkhordari, S. Samnejad & S.-H. Abtahi. (2023) Acetazolamide and bevacizumab combination therapy versus bevacizumab monotherapy in macular edema secondary to retinal vein occlusion. Journal Français d'Ophtalmologie 46:4, pages 322-326.
Crossref
Crossref
Rie Osaka, Yuki Muraoka, Yuki Nakano, Yukari Takasago, Yuta Koyama, Yukiko Miyoshi, Akitaka Tsujikawa & Kiyoshi Suzuma. (2020) One-year results of anti-vascular endothelial growth factor therapy combined with triamcinolone acetonide for macular edema associated with branch retinal vein occlusion. Japanese Journal of Ophthalmology 64:6, pages 605-612.
Crossref
Crossref